Integrating Pathology Into the Care Team – A Workflow Solution for Integrated Healthcare Data Exchange and Collaboration

  • Jun 15, 2018

At the 2018 Executive War College event, XIFIN Vice President of Informatics, Patricia Goede and I discussed the value and importance of integrating pathologists and pathology lab data systems into the cancer care team workflow. Below you’ll find a recap of our talk about integrated pathology approaches—how they impact diagnostics, coordination of care, and improve the patient experience and...

Read


Quality Initiatives in Cancer Care at the 54th Annual 2018 American Society of Clinical Oncology

  • Jun 12, 2018

I recently attended the ASCO 2018 Annual Meeting on June 1st at the McCormick Place in Chicago where informative educational and scientific sessions highlighted the latest in cancer care treatments. This year attendees connected and shared with peers the latest in cancer treatment, care, and policy that impact the field of oncology and hematology. Among the many subjects...

Read


PAMA: Strategies Moving Forward

  • Jun 6, 2018

Moving forward in light of the impact of the Protecting Access to Medicare Act (PAMA) of 2014 requires laboratories to demonstrate fiscal acumen in terms of their contracting process and reimbursement due diligence. This will support: Help mitigate lost revenue from the current round of PAMA fe schedule cutsPreparation for the next PAMA data collection periodPrepare labs from the next...

Read


Physician Adoption of Remote Patient Monitoring Services in Healthcare

  • Jun 6, 2018

The emergence of wearable devices for remote patient monitoring is rapidly helping physicians improve patient care along with having the potential to dramatically lower healthcare costs.   According to Goldman Sachs, remote patient monitoring provides the potential for 200 billion dollar annual savings in healthcare costs, targeting the fields of heart disease, COPD/Asthma and diabetes...

Read


Is it Time for Soft Law to Apply to Commercial Payor Policies?

  • May 21, 2018

I recently attended the 7th Annual ASU Workshop on Regulation and Reimbursement of Molecular Diagnostics.  This workshop is sponsored by the Sandra Day O’Connor School of Law.  In a day completely full of informative presentations and stimulating discussion, I was most taken by Kirk T. Hartley’s presentation “Experimental Exclusions and Other State Law Failures; A 'Soft Law' ...

Read


What does the Amazon, JP Morgan, and Berkshire Hathaway Partnership Mean for Laboratories?

  • May 17, 2018

Amazon, JP Morgan, and Berkshire Hathaway announced they are planning to get more involved with healthcare, particularly to lower costs. This partnership is initially focusing on reinventing healthcare for their employees, as the three firms form an independent healthcare company for their employees in the United States.As healthcare costs for employers and employees continue to rise, as do...

Read


Diagnostic Data in Precision Medicine: Explore How Laboratory Informatics Impacts Population Management and Patient Care

  • May 16, 2018

At this year’s Executive War College, I was joined by Diana R. Brooks, Director of Program Development, Anatomic Pathology, here at XIFIN, and Julie Ramage, National Account Director, Diagnostics, at Pfizer Oncology  as we presented strategies and the value proposition of diagnostic data in precision medicine. This panel explored how implementing a laboratory informatics infrastructure...

Read


How to Prepare Your Lab for Next-Gen Sequencing and Big Data Science

  • May 11, 2018

Industry experts estimate that anywhere between 100 million to 2 billion genomes will be sequenced by 2025. With the growing demand for next-generation sequencing (NGS), from bases to whole genomes, and the growing demand for sequence-based drug discovery applications and diagnostic testing, there’s no denying that labs will need to accommodate a huge amount of data very soon.What does genomics...

Read